Department of Critical Care Medicine, Nanjing Zhong-da Hospital, School of Medicine, Southeast University
Nanjing, Jiangsu, 210009, China
NCT Number: NCT03237806
The acute respiratory distress syndrome (ARDS) is characterized by severe respiratory failure. Open Lung and Lung Protective Strategy have been proved to improve mortality of ARDS patients. Preserving spontaneous breathing (SB) is good for inflating the lung lobe near diaphram during mechanical ventilation, however, strong respiratory drive could generate more transpulmonary pressure in ARDS patients, which increase the stress and strain in injured lung. Nonetheless, it's not clear if sedative has any effects on transpulmonary pressure of ARDS patients.The purpose of this study is to investigate the effects of sedation on transpulmonary pressure of ARDS patients.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Nanjing, Jiangsu, 210009, China
Further study details as provided by Nanjing Zhong-da Hospital, School of Medicine, Southeast University
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Midazolam intravenous continusly infusion, Deep sedated (Ramsay 5)
Other names: Deep sedation
Midazolam intravenous continusly infusion, Light sedated (Ramsay 3)
Other names: Light sedation
Time frame: 15 minutes during deep or light sedation
Ispiratory transpulmonary pressure and expiratory transpulmonary pressure measured during sedation
Time frame: 15min during deep or light sedation
Crs measured during deep or light sedation
Time frame: 15 minutes
ABG after deep or light sedation
Time frame: 15 minutes
MAP during deep or light sedation
Southeast University, China
Other
Effects of Sedation on Transpulmonary Pressure and Lung Homogenous of ARDS Patients
Acronym: ARDS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06808438
ARDS
Chengdu, Sichuan, China
View Trial DetailsNCT06511622
ARDS
Berlin, Germany
View Trial DetailsNCT04371029
ARDS, COVID-19
Bordeaux, France
View Trial DetailsNCT04402879
ARDS, Acute Respiratory Distress Syndrome
Calgary, Alberta, Canada
View Trial Details